More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY

Fleseriu, Maria; Führer-Sakel, Dagmar; J van der Lely, Aart; De Marinis, Laura; Brue, Thierry; van der Lans-Bussemaker, Joli; Hey-Hadavi, Judith; Camacho-Hubner, Cecilia; P Wajnrajch, Michael; Rao Valluri, Srinivas; Anthony Palladino, Andrew; Gomez, Roy; Salvatori, Roberto

doi:10.1530/eje-21-0239

Public

More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY

Shared by NobleBlocks on Oct 1, 2021 • 12:00 AM UTC

Authors:

Maria Fleseriu

Dagmar Führer-Sakel

Aart J van der Lely

Abstract

Objective To report the final long-term safety and efficacy analyses of patients with acromegaly treated with pegvisomant from the ACROSTUDY. Design Global (15 countries), multicentre, non-interventional study (2004–2017). Methods The complete ACROSTUDY cohort comprised patients with acromegaly, who...

Discussions